One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Malaria vaccines: a test for global health
doi : 10.1016/S0140-6736(24)00235-6
Volume 403, Issue 10426, 10–16 February 2024, Page 503
Malaria vaccines for children: and now there are two
*Vasee Moorthy, Mary J Hamel, Peter G Smith
doi : 10.1016/S0140-6736(23)02743-5
Volume 403, Issue 10426, 10–16 February 2024, Pages 504-505
The cerebroplacental ratio: a new standard diagnostic tool at term gestation to assess fetal risk in labour?
Sharon C Reale, *Michaela K Farber
doi : 10.1016/S0140-6736(23)02453-4
Volume 403, Issue 10426, 10–16 February 2024, Pages 506-508
Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality
Martin C Gulliford, Claire J Steves
doi : 10.1016/S0140-6736(23)02622-3
Volume 403, Issue 10426, 10–16 February 2024, Pages 508-509
Scientific advisory councils in the COVID-19 response
Jean-François Delfraissy, Mary Horgan, K?re M?lbak, Fernando Soria Sim?n, Tanja Stadler, Jaap van Dissel, Steven Van Gucht, Walter Ricciardi, Lothar Wieler, Patrick Vallance, on behalf of Covid-19 National Scientific Advisory Councils: Presidents or Representatives
doi : 10.1016/S0140-6736(23)01846-9
Volume 403, Issue 10426, 10–16 February 2024, Pages 510-512
Harnessing tobacco harm reduction
Jean-François Delfraissy, Mary Horgan, K?re M?lbak, Fernando Soria Sim?n, Tanja Stadler, Jaap van Dissel, Steven Van Gucht, Walter Ricciardi, Lothar Wieler, Patrick Vallance, on behalf of Covid-19 National Scientific Advisory Councils: Presidents or Representatives
doi : 10.1016/S0140-6736(24)00140-5
Volume 403, Issue 10426, 10–16 February 2024, Pages 512-514
Offline: Is there still time?
Richard Horton
doi : 10.1016/S0140-6736(24)00231-9
Volume 403, Issue 10426, 10–16 February 2024, Page 515
WHO rolls out plan to strengthen country offices
John Zarocostas
doi : 10.1016/S0140-6736(24)00232-0
Volume 403, Issue 10426, 10–16 February 2024, Page 516
Health and aid organisations give UNRWA warning
Sharmila Devi
doi : 10.1016/S0140-6736(24)00233-2
Volume 403, Issue 10426, 10–16 February 2024, Page 517
Health in Brazil: 1 year of Lula
Lise Alves
doi : 10.1016/S0140-6736(24)00234-4
Volume 403, Issue 10426, 10–16 February 2024, Pages 518-519
Ashwin Vasan: committed to addressing NYC's health challenges
Udani Samarasekera
doi : 10.1016/S0140-6736(24)00200-9
Volume 403, Issue 10426, 10–16 February 2024, Page 520
Home planet
Gavin Francis
doi : 10.1016/S0140-6736(24)00201-0
Volume 403, Issue 10426, 10–16 February 2024, Pages 521-522
Hospital dogs and Sigrid Nunez's The Friend
Aminatta Forna, *Daniel Marchalik
doi : 10.1016/S0140-6736(24)00202-2
Volume 403, Issue 10426, 10–16 February 2024, Page 523
Sean Healy
Andrew Green
doi : 10.1016/S0140-6736(24)00203-4
Volume 403, Issue 10426, 10–16 February 2024, Page 524
R21/Matrix-M vaccine: optimising supply, maximising impact
Chukwudi A Nnaji, Uchenna A Amaechi, Charles S Wiysonge
doi : 10.1016/S0140-6736(23)02716-2
Volume 403, Issue 10426, 10–16 February 2024, Page 525
Draft of WHO Pandemic Agreement plays down primary prevention
doi : 10.1016/S0140-6736(24)00066-7
Volume 403, Issue 10426, 10–16 February 2024, Pages 525-526
Health implications of GSK's departure from Nigeria
Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori
doi : 10.1016/S0140-6736(23)01913-X
Volume 403, Issue 10426, 10–16 February 2024, Pages 526-527
Post-earthquake demolition in Türkiye: health implications
*Carla Ancona, Francesco Forastiere
doi : 10.1016/S0140-6736(23)02460-1
Volume 403, Issue 10426, 10–16 February 2024, Pages 527-528
Data disaggregation and unintended consequences
Y Tony Yang, Sawali Sudarshan
doi : 10.1016/S0140-6736(23)01361-2
Volume 403, Issue 10426, 10–16 February 2024, Page 528
Intramuscular vaccination needle length: a call to arms
Marjan Doppen, Ciléin Kearns, Thomas Hills, Mark Weatherall, *Richard Beasley
doi : 10.1016/S0140-6736(23)02222-5
Volume 403, Issue 10426, 10–16 February 2024, Pages 528-529
Vaccination and the defence of democracy
Roger L Albin
doi : 10.1016/S0140-6736(23)01897-4
Volume 403, Issue 10426, 10–16 February 2024, Page 529
Vaccination and the defence of democracy – Authors' reply
Richard M Carpiano, Timothy Callahan, Jad A Elharake, Peter Hotez, on behalf of The Lancet Commission on Vaccine Hesitancy, Acceptance, and Demand in the United States
doi : 10.1016/S0140-6736(23)01895-0
Volume 403, Issue 10426, 10–16 February 2024, Pages 529-530
Manufactured scarcity and the allocation of scarce resources
James Smith
doi : 10.1016/S0140-6736(23)02886-6
Volume 403, Issue 10426, 10–16 February 2024, Pages 530-531
Manufactured scarcity and the allocation of scarce resources
Mitchell Berger
doi : 10.1016/S0140-6736(23)02887-8
Volume 403, Issue 10426, 10–16 February 2024, Page 531
Manufactured scarcity and the allocation of scarce resources
*Stephen P Miranda, Justin T Clapp
doi : 10.1016/S0140-6736(23)02888-X
Volume 403, Issue 10426, 10–16 February 2024, Pages 531-532
Manufactured scarcity and the allocation of scarce resources – Authors' reply
*Ezekiel J Emanuel, Govind Persad
doi : 10.1016/S0140-6736(23)02885-4
Volume 403, Issue 10426, 10–16 February 2024, Page 532
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
Mehreen S Datoo, Alassane Dicko*, Halidou Tinto*, Jean-Bosco Ouédraogo, Mainga Hamaluba†, Ally Olotu†, Emma Beaumont, Fernando Ramos Lopez, Hamtandi Magloire Natama, Sophie Weston, Mwajuma Chemba, Yves Daniel Compaore, Djibrilla Issiaka, Diallo Salou, Athanase M Some, Sharon Omenda, Alison Lawrie, Philip Bejon, Harish Rao, Daniel Chandramohan, Rachel Roberts, Sandesh Bharati, Lisa Stockdale, Sunil Gairola, Brian M Greenwood, Katie J Ewer‡, John Bradley, Prasad S Kulkarni, Umesh Shaligram, Adrian V S Hill, the R21/Matrix-M Phase 3 Trial Group§
doi : 10.1016/S0140-6736(23)02511-4
Volume 403, Issue 10426, 10–16 February 2024, Pages 533-544
Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial
Marta Rial-Crestelo, Marek Lubusky, Mauro Parra-Cordero, Ladislav Krofta, Anna Kajdy, Eyal Zohav, Elena Ferriols-Perez, Rogelio Cruz-Martinez, Marian Kacerovsky, Elena Scazzocchio, Lucie Roubalova, Pamela Socias, Lubomir Ha?l?k, Jan Modzelewski, Eran Ashwal, Julia Castell?-Cesari, Monica Cruz-Lemini, Eduard Gratacos*, Francesc Figueras*, on behalf of the RATIO37 Study Groupâ€
doi : 10.1016/S0140-6736(23)02228-6
Volume 403, Issue 10426, 10–16 February 2024, Pages 545-553
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales
doi : 10.1016/S0140-6736(23)02467-4
Volume 403, Issue 10426, 10–16 February 2024, Pages 554-566
Localised re-expansion pulmonary oedema following spontaneous pneumothorax
Mar?a Paula Abaunza-Camacho, Javier Leonardo Galindo, Jorge Alberto Carrillo
doi : 10.1016/S0140-6736(23)02895-7
Volume 403, Issue 10426, 10–16 February 2024, Page 567
A new age of precision gene therapy
Axel Schambach, Christian J Buchholz, Raul Torres-Ruiz, Klaus Cichutek, Michael Morgan, Ivana Trapani, Hildegard Büning
doi : 10.1016/S0140-6736(23)01952-9
Volume 403, Issue 10426, 10–16 February 2024, Pages 568-582
Population screening requires robust evidence—genomics is no exception
Clare Turnbull, Helen V Firth, Andrew O M Wilkie, William Newman, F Lucy Raymond, Ian Tomlinson, Robin Lachmann, Caroline F Wright, Sarah Wordsworth, Angela George, Margaret McCartney, Anneke Lucassen
doi : 10.1016/S0140-6736(23)02295-X
Volume 403, Issue 10426, 10–16 February 2024, Pages 583-586
